Integrative analysis of CRISPR/Cas9 target sites in the human HBB gene

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Luo, Yumei ^a   Zhu, Detu ^b   Zhang, Zhizhuo ^b   Chen, Yaoyong ^a   Sun, Xiaofang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN; TRANSCRIPTION FACTOR; PROTEIN BINDING;

ADULT; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CRISPR CAS SYSTEM; EMBRYO; EXON; GENE TARGETING; GENETIC ANALYSIS; GENETIC CODE; GLOBIN GENE; HUMAN; INTRON; NONHUMAN; PHYLOGENY; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETICS; METABOLISM; PROTEIN TERTIARY STRUCTURE;

BETA-GLOBINS; BINDING SITES; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; EXONS; HUMANS; INTRONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 84928336384     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/514709     Document Type: Article

References (30)

1. D. Zhu, D. H. Lam, Y. I. Purwanti et al. , "Systemic delivery of fusogenic membrane glycoprotein-expressing neural stem cells to selectively kill tumor cells," MolecularTherapy, vol. 21, no. 8, pp. 1621-1630, 2013.
2. D. Zhu, C. Chen, Y. I. Purwanti et al. , "Induced pluripotent stem cell-derived neural stem cells transduced with baculovirus encoding CD40 ligand for immunogene therapy in mouse models of breast cancer," Human Gene Therapy, vol. 25, no. 8, pp. 747-758, 2014.
3. Y. Luo and D. Zhu, "Combinatorial control of transgene expression by hypoxia-responsive promoter and MicroRNA regulation for neural stem cell-based cancer therapy," BioMed Research International, vol. 2014, Article ID 751397, 9 pages, 2014.
4. Y. Luo, D. Zhu, D. H. Lam et al. , "A double-switch cell fusioninducible transgene expression system for neural stem cellbased antiglioma gene therapy," Article ID 649080, Stem Cells International. In press.
5. F. Soldner, J. Laganiere, A. W. Cheng et al. , "Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations," Cell, vol. 146, no. 2, pp. 318-331, 2011.
6. Y. Luo, J. Li, D. Zhu, Y. Fan, S. Li, and X. Sun, "High-resolution chromosomal microarray analysis of early-stage human embryonic stem cells reveals an association between X chromosome instability and skewed X inactivation," Cell and Bioscience, vol. 4, no. 1, article 74, 2014.
7. L. Cong,F. A. Ran,D. Cox et al. , "Multiplex genome engineering using CRISPR/Cas systems," Science, vol. 339, no. 6121, pp. 819-823, 2013.
8. P. Mali, L. Yang, K. M. Esvelt et al. , "RNA-guided human genome engineering via Cas9," Science, vol. 339, no. 6121, pp. 823-826, 2013.
9. F. A. Ran, P. D. Hsu, J. Wright, V. Agarwala, D. A. Scott, and F. Zhang, "Genome engineering using the CRISPR-Cas9 system," Nature Protocols, vol. 8, no. 11, pp. 2281-2308, 2013.
10. Y. Wu, D. Liang, Y. Wang et al. , "Correction of a genetic disease in mouse via use of CRISPR-Cas9," Cell Stem Cell, vol. 13, no. 6, pp. 659-662, 2013.
11. G. Schwank, B.-K. Koo, V. Sasselli et al. , "Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients," Cell Stem Cell, vol. 13, no. 6, pp. 653-658, 2013.
12. P. Mali, J. Aach, P. B. Stranges et al. , "CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering," Nature Biotechnology, vol. 31, no. 9, pp. 833-838, 2013.
13. Y. Fu, J. A. Foden, C. Khayter et al. , "High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells," Nature Biotechnology, vol. 31, no. 9, pp. 822-826, 2013.
14. P. D. Hsu, D. A. Scott, J. A. Weinstein et al. , "DNA targeting specificity of RNA-guided Cas9 nucleases," Nature Biotechnology, vol. 31, no. 9, pp. 827-832, 2013.
15. T. J. Cradick, E. J. Fine, C. J. Antico, and G. Bao, "CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity," Nucleic Acids Research, vol. 41, no. 20, pp. 9584-9592, 2013.
16. F. A. Ran, P. D. Hsu, C.-Y. Lin et al. , "Double nicking by RNAguided CRISPR cas9 for enhanced genome editing specificity," Cell, vol. 154, no. 6, pp. 1380-1389, 2013.
17. M. Ma, A. Y. Ye, W. Zheng, and L. Kong, "A guide RNA sequence design platform for the CRISPR/Cas9 system for model organism genomes," BioMed Research International, vol. 2013, Article ID 270805, 4 pages, 2013.
18. S. Bae, J. Park, and J. S. Kim, "Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases," Bioinformatics, vol. 30, no. 10, pp. 1473-1475, 2014.
19. A. Xiao, Z. Cheng, L. Kong et al. , "CasOT: a genome-wide Cas9/gRNA off-target searching tool," Bioinformatics, vol. 30, no. 8, pp. 1180-1182, 2014.
20. T. Hubbard, D. Barker, E. Birney et al. , "The Ensembl genome database project," Nucleic Acids Research, vol. 30, no. 1, pp. 38-41, 2002.
21. N. Hulo, A. Bairoch, V. Bulliard et al. , "The PROSITE database," Nucleic Acids Research, vol. 34, pp. D227-D230, 2006.
22. K. R. Rosenbloom, T. R. Dreszer, J. C. Long et al. , "ENCODE whole-genome data in the UCSC Genome Browser: update 2012,"Nucleic Acids Research, vol. 40,no. 1, pp. D912-D917, 2012.
23. A. Mathelier, X. Zhao, A. W. Zhang et al. , "JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles," Nucleic Acids Research, vol. 42, no. 1, pp. D142-D147, 2014.
24. S. T. Sherry,M.-H. Ward,M. Kholodov et al. , "dbSNP: theNCBI database of genetic variation," Nucleic Acids Research, vol. 29, no. 1, pp. 308-311, 2001.
25. D. Wheeler, R. M. Hope, S. J. B. Cooper, A. A. Gooley, and R. A. B. Holland, "Linkage of the beta-like omega-globin gene to α-like globin genes in an Australian marsupial supports the chromosome duplication model for separation of globin gene clusters," Journal of Molecular Evolution, vol. 58, no. 6, pp. 642-652, 2004.
26. R. C. Hardison, "New views of evolution and regulation of vertebrate β-like globin gene clusters from an orphaned gene in marsupials," Proceedings of the National Academy of Sciences of theUnited States of America, vol. 98,no. 4, pp. 1327-1329, 2001.
27. M.-H. Lee, R. Shroff, S. J. B. Cooper, and R. Hope, "Evolution and molecular characterization of a beta-globin gene from the Australian Echidna Tachyglossus aculeatus (Monotremata)," Molecular Phylogenetics and Evolution, vol. 12, no. 2, pp. 205-214, 1999.
28. T. Wang, J. J. Wei, D. M. Sabatini, and E. S. Lander, "Genetic screens in human cells using the CRISPR-Cas9 system," Science, vol. 343, no. 6166, pp. 80-84, 2014.
29. B. Giardine, J. Borg, E. Viennas et al. , "Updates of the HbVar database of human hemoglobin variants and thalassemiamutations," Nucleic Acids Research, vol. 42, no. 1, pp. D1063-D1069, 2014.
30. G. Bungartz, H. Land,D. T. Scadden, and S. G. Emerson, "NFY is necessary for hematopoietic stem cell proliferation and survival," Blood, vol. 119, no. 6, pp. 1380-1389, 2012.